---
schema_version: "secwatch.filing_event.v1"
accession: "0001412408-21-000090"
form_type: "8-K"
ticker: "PHR"
cik: "0001412408"
company_name: "Phreesia, Inc."
filed_at: "2021-12-08T23:59:59+00:00"
generated_at: "2026-06-28T02:47:05.814562+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Phreesia Q3 revenue $55.9M (+45% YoY); FY22 outlook raised to $211M

## Summary
- Revenue $55.9M, up 45% YoY; net loss $36.3M ($0.71/share) vs $6.7M loss prior year.
- Adjusted EBITDA -$17.6M vs +$1.2M a year ago, reflecting increased growth investment.
- FY2022 revenue outlook raised to $211M from $195-198M; FY2023 growth guided 20-25%.
- Cash $400.4M after follow-on offering generating $245.8M net proceeds.
- Agreed to acquire Insignia Health for $35M cash; adds Patient Activation Measure (PAM).

## SEC filing metadata
- accession: 0001412408-21-000090
- form_type: 8-K
- ticker: PHR
- cik: 0001412408
- company_name: Phreesia, Inc.
- filed_at: 2021-12-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1412408/000141240821000090/0001412408-21-000090-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1412408/000141240821000090/phr-20211208.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001412408-21-000090
- JSON: https://secwatch.observer/filing/0001412408-21-000090.json
- Plain text: https://secwatch.observer/filing/0001412408-21-000090.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.